NCT06353529 - Postop Pain Management in Pituitary Tumour Patients | Biotech Hunter

Enrollment

108

Participants

Timeline

Start Date

November 25, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

January 31, 2026

Conditions

PituitaryPain, Postoperative

Interventions

DRUG

Bupivacaine-Epinephrine 0.5%-1:200,000 Injectable Solution

2mL injection bilateral (4mL total) of 0.5% bupivacaine with 1:200,000 epinephrine solution, 20G needle, sterile, sphenopalatine ganglion; nerve block

DRUG

Placebo

2mL injection bilateral (4mL total) 0.9% saline solution, 20G needle, sterile, sphenopalatine ganglion; nerve block

DRUG

Sham Comparator

Participants receive no additional study injections

Trial Locations (1)

L8L 2X2

RECRUITING

Hamilton General Hospital, Hamilton

All Listed Sponsors

lead

Hamilton Health Sciences Corporation

OTHER